相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial
Carole Mercier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview
Jimm Grimm et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
Yizhou Zhao et al.
RADIATION ONCOLOGY (2020)
SABR-COMET: harbinger of a new cancer treatment paradigm
Billy W. Loo et al.
LANCET (2019)
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
David A. Palma et al.
LANCET (2019)
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial
David A. Palma et al.
BMC CANCER (2019)
Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases
Miguel A. Palacios et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Donna H. Murrell et al.
RADIATION ONCOLOGY (2018)
UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy
G.G. Hanna et al.
CLINICAL ONCOLOGY (2017)
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Daniel R. Gomez et al.
LANCET ONCOLOGY (2016)
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree
Justin M. Haseltine et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Stereotactic Ablative Body Radiotherapy for Lung Cancer
K. N. Franks et al.
CLINICAL ONCOLOGY (2015)
Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy
Talha Shaikh et al.
CANCER TREATMENT REVIEWS (2014)
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial
David A. Palma et al.
BMC CANCER (2012)
Oligometastases revisited
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Stanley H. Benedict et al.
MEDICAL PHYSICS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
An overview of hypofractionation and introduction to this issue of Seminars in Radiation Oncology
Robert D. Timmerman
SEMINARS IN RADIATION ONCOLOGY (2008)
Analysis of radiation-induced liver disease using the Lyman NTCP model
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
分享论文
